Last reviewed · How we verify
NCT07006181
Effectiveness of Cyproheptadine Hydrochloride Against Appetite to Improve Children's Nutritional Status
NA trial testing cyproheptadine hydrochloride in Appetite Loss in 44 participants. Completed in 31 March 2025.
28 February 2025
Quick facts
| Lead sponsor | Indonesia University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | supportive care |
| Enrollment | 44 |
| Start date | 4 November 2024 |
| Primary completion | 28 February 2025 |
| Estimated completion | 31 March 2025 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- cyproheptadine hydrochloride (CYPROHEPTADINE) — full drug profile →
- Giving placebo divided by 2 dose every 12 hours for 4 weeks.
Conditions studied
- Appetite Loss — all drugs for Appetite Loss →
Sponsor
Indonesia University
Who can join
Adults 1 to 5, any sex, with Appetite Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn about the benefits of Cyproheptadine hydrochloride in increasing appetite as well as its effect on weight gain in children aged 1-5 years who have difficulty eating. The main questions it aims to answer are: * Is Cyproheptadine hydrochloride useful in increasing appetite in children? * Is the Cyproheptadine hydrochloride dose given effective and efficient regarding the improvement of a child's appetite? Can giving Cyproheptadine hydrochloride improve nutritional status of children? * How long can Cyproheptadine hydrochloride be given to increase appetite in children and what are the side effects? Participants will: * Take the Cyproheptadine hydrochloride every day, twice a day for 4 weeks (intervention group); take the placebo (control group) * Have their ECAST score (score for measuring appetite in children), anthropometric measurement before and after intervention at the second visit (2 weeks), third visit (4 weeks and stop intervention), and fourth visit (8 weeks after stopping the intervention)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07006181
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Appetite Loss
Currently open trials in the same condition.
- NCT06478147 — Effect of a Novel Protein Ingredient Combined With Oral Nutritional Supplement on Appetite in Older Adults · NA · active not recruiting
- NCT04859296 — AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT) · Phase 1 · active not recruiting
Other Indonesia University trials
Trials by the same sponsor.
- NCT07137130 — Secretome TGF Beta 3 · NA · not yet recruiting
- NCT07420335 — Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mastectomy · NA · not yet recruiting
- NCT07278284 — The Effectiveness of Press Needle Acupuncture on Preoperative Anxiety in Tympanoplasty and Mastoidectomy · NA · recruiting
- NCT07337187 — Effect of Thread-Embedding Acupuncture at EX-B2 on Pain and Quality of Life in Chronic Low Back Pain · NA · not yet recruiting
- NCT07242001 — Laser Acupuncture for Otitis Media With Effusion in Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07006181 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Indonesia University
- Last refreshed: 10 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07006181.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing